Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-16-008933
Filing Date
2016-04-14
Accepted
2016-04-14 17:20:46
Documents
90
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1446024
2 ex10-34.htm EX-10.34 467246
3 ex10-35.htm EX-10.35 12213
4 ex21.htm EX-21 2026
5 ex31-1.htm EX-31.1 19546
6 ex31-2.htm EX-31.2 19873
7 ex32-1.htm EX-32.1 9678
8 image_001.jpg GRAPHIC 4605
  Complete submission text file 0001493152-16-008933.txt   6034767

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE trgm-20151231.xml EX-101.INS 803071
10 XBRL SCHEMA FILE trgm-20151231.xsd EX-101.SCH 59278
11 XBRL CALCULATION FILE trgm-20151231_cal.xml EX-101.CAL 81986
12 XBRL DEFINITION FILE trgm-20151231_def.xml EX-101.DEF 202635
13 XBRL LABEL FILE trgm-20151231_lab.xml EX-101.LAB 435916
14 XBRL PRESENTATION FILE trgm-20151231_pre.xml EX-101.PRE 343647
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

EIN.: 205863618 | Fiscal Year End: 1209
Type: 10-K | Act: 34 | File No.: 000-53071 | Film No.: 161572552
SIC: 2834 Pharmaceutical Preparations